Prizes
College of Optometrists Research Excellence Award: The Philip Cole Prize for Practice Based Research 2018
NIHR Clinical Doctoral Fellowship
NIHR Thames Valley and South Midland Health Research Award 2016 for "Outstanding Research Practitioner".
Best Poster Prize Hospital Optometrists Annual Conference 2016
"VITAMIN A DEFICIENCY IN AN AUTISTIC DIET; A CASE STUDY (Watch out for those Fussy Eaters)" Charles Cottriall and Jasleen K Jolly
Colleges
Research groups
Jasleen Kaur Jolly
DPhil MSc BSc (Hons) MCOptom
Senior Clinical Research Fellow
- Specialist Research Optometrist
- Vision Scientist
- Visual Neuroscientist
- Clinical electrophysiologist (ophthalmic)
Jasleen Kaur Jolly is an optometrist working between the Nuffield Laboratory of Ophthalmology and Wellcome Integrative Neuroimaging Centre, University of Oxford, and Oxford Eye Hospital. She studied at Cardiff University, the University of Manchester, and Oxford University (Merton College) working across the world in various settings to gain a wide range of experience, including electrophysiology. She is actively involved in clinical research in the fields of retinal gene therapy, surgical outcomes and low vision. Her main interest is improving outcome measures following interventions for ophthalmic diseases and promoting a career in clinical translational research for optometrists embedded in multidisciplinary teams.
She is keen to develop new and innovative ways to assess visual measures and has promoted cross domain working. For this reason she was shortlisted for 2 AGI awards in 2015;
The Award for Excellence in Research & Development, and The Award for Excellence With Impact.
She also won the NIHR Thames Valley Health Research Award 2016 for "Outstanding Research Practitioner", and the College of Optometrists Philip Cole Prize for Practice Based Research in November 2018.
Jasleen's research specialises in the translational front to take lab and theoretical research into human clinical trials for ocular conditions, and ultimately treatment. There are 3 key areas of interest:
1) Investigation of visual function and retinal structure in inherited retinal degeneration. Using this knowledge to help design clinical protocols for new interventional therapies, with a special interest in first in man gene therapy trials. This knowledge of the disease process is also used to improve low vision care for patients.
2) The interaction between the eye and brain in eye disease. Of specific interest is the impact of visual field loss on the way the information is processed in the brain, incorporating neuroscience and ophthalmology.
3) The psychological impact of vision loss and improving this aspect of care.
Websites
-
Intersection between basic neuroscience and clinical research
Interviewed by Shraddha Shah, neuroscientist
-
Podcast
College of Optometrists
- Empathy in Low Vision
- ORCID ID
- An alternative career in optometry
- Research rewards
- Optometry Today interview
- GIS for Ophthalmology data
Key publications
-
Journal article
Edwards TL. et al, (2016), N Engl J Med, 374, 1996 - 1998
-
Chapter
Talib M. et al, (2018), 1715, 339 - 349
Recent publications
-
Journal article
Dubis AM. et al, (2021), Journal of Clinical Medicine, 10, 232 - 232
-
Journal article
Wood LJ. et al, (2021), Ophthalmic and Physiological Optics
-
Journal article
Jolly JK. et al, (2020), Journal of Neuroscience Methods, 109023 - 109023
-
Journal article
Jolly JK. et al, (2020), British Journal of Ophthalmology
-
Journal article
Al-khuzaei S. et al, (2020), Genes, 11, 1288 - 1288
-
Journal article
Pfau M. et al, (2020), Prog Retin Eye Res
-
Journal article
Ayton LN. et al, (2020), Translational Vision Science & Technology, 9, 25 - 25
-
Assessing Residual Photoreceptor Morphology in Choroideremia
Conference paper
Dubis AM. et al, (2020), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 61
-
Retinal Gene Therapy in X-Linked Retinitis Pigmentosa Caused by Mutations in RPGR: Results at 6 Months in a First in Human Clinical Trial
Conference paper
Cehajic-Kapetanovic J. et al, (2020), MOLECULAR THERAPY, 28, 1 - 1
-
Journal article
Buckley TMW. et al, (2020), Clin Exp Ophthalmol
-
Journal article
Menghini M. et al, (2020), Ophthalmologica
-
Journal article
Cehajic-Kapetanovic J. et al, (2020), Nature Medicine